3 Peninsula biotech IPOs seek to raise more than $400 million

From rare diseases to cancer and NASH, this trio of companies would be the seventh, eighth and nine Bay Area life sciences IPOs this year.

3 Peninsula biotech IPOs seek to raise more than $400 million



Source

Some local news is curated - Original might have been posted at a different date/ time! Click the source link for details.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.